Monoclonal antibodies have now been in use in the myeloma clinic since November of 2015. Dr. Gareth Morgan of the University of Arkansas Medical Sciences (UAMS) Myeloma Institute shares how they work and where the field is headed. He mentions the development of bi-specific antibodies, which are new drugs that can link an immune cell with the target on the surface of myeloma cells for greater specificity and impact. Learn more about this new class of drugs in this recent show on Myeloma Crowd Radio.
What Do Monoclonal Antibodies Do in Myeloma? from Patient Power on Vimeo.Monoclonal antibodies have now been in use in the myeloma clinic since November of 2015. Dr. Gareth Morgan of the University of Arkansas Medical Sciences (UAMS) Myeloma Institute shares how they work and where the field is headed. He mentions the development of bi-specific antibodies, which are new drugs that can link an immune cell with the target on the surface of myeloma cells for greater specificity and impact. Learn more about this new class of drugs in this recent show on Myeloma Crowd Radio.
What Do Monoclonal Antibodies Do in Myeloma? from Patient Power on Vimeo.about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.